Drawing for HOLDING F.I.S.

USPTO serial 79138349

HOLDING F.I.S.

Reviewed by CopyMark Law Group

Reg. 4686295Status 404
Filing date
Status date
Registration date
Feb 17, 2015
Examiner
LORENZO, KATHLEEN H
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HOLDING F.I.S.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, drugs for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; veterinary preparations, namely, drugs for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs, for domestic, farm and marine animals; sanitary preparations for medical purposes; dietary substances for supplements adapted for medical or veterinary use, namely, food for babies; dietary supplements for humans and animals; medical plasters; materials for dressings, namely, medical and surgical dressings; material for stopping teeth, dental wax; acids for pharmaceutical purposes, namely, amino acids; thermal water for medical purposes, namely, nutritionally fortified water; nutritional supplements; medicinal alcohol; anaesthetics; fumigating sticks; antibiotics; antioxidant pills; antiseptics; sanitary towels; bath preparations, medicated; balms for medical purposes; medicated confectionery; sticking plasters for medical use; adjuvants for medical purposes; collyrium; medicated compresses; chemical contraceptives; cultures of microorganisms for medical and veterinary use; depuratives for the body; digestives for pharmaceutical purposes; drugs for medical purposes, namely, drugs for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; medicinal herbs; medicinal fungi; meal for pharmaceutical purposes; febrifuges; milk ferments for pharmaceutical purposes; chewing gum for medical purposes; insecticides; insect repellents; dietary and nutritional supplements; vitamin supplement products, namely, vitamin supplements; mineral food supplements; nutritional supplements for medical purposes; protein dietary supplements; mineral food supplements; laxatives; lotions for pharmaceutical purposes; skin lotions for veterinary purposes; medicines for human purposes, namely, medicines for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; medicines for dental purposes; medicines for veterinary purposes, namely, drugs for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs, for domestic, farm and marine animals; serotherapeutic medicines; medicinal oils; royal jelly dietary supplements; parasiticides; lozenges for pharmaceutical purposes; pesticides; medical slimming pills; pomades for medical purposes; biological preparations for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs, for veterinary purposes, for domestic, farm and marine animals; chemical preparations for pharmaceutical purposes, namely, for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; chemical preparations for medical purposes, namely, for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; chemical preparations for veterinary purposes, namely, for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; vitamin preparations; hemorrhoid treatment preparations; antiparasitic preparations; mothproofing preparations; anti-uric preparations; biological preparations, namely, for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; pharmaceutical preparations for skin care; diagnostic preparations for medical purposes; air purifying preparations; radioactive substances for medical purposes; sodium salts for medical purposes; medicated serums for treatment of skin, lips, hair; soporifics; radiological contrast substances for medical purposes; dietetic substances adapted for medical use, namely, dietary supplements; herbal teas for medicinal purposes; vaccines; vermifuges, namely, medicines for expelling intestinal wormsSECTION 71 - CANCELLED—
035Publicity; business management; business administration; office functions; wholesale and retail store services featuring medical goods, cosmetics, antiseptic and insecticides, dietary supplements for human and animal nutrition, medical contrast agents for diagnostics, micronization and lyophilization; rental of advertising time on communication media; commercial administration of the licensing of the goods and services of others; cost price analysis; commercial and industrial management assistance; business management consultancy; demonstration of goods; organization of exhibitions and trade fairs for commercial and advertising purposes; promoting the goods of others on communication media, for retail purposes; sales promotion for others; on-line advertising on a computer network; sponsorship search; business research; procurement services for others, namely, purchasing pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical suppliesSECTION 71 - CANCELLED—
036Insurance underwriting for all types of insurance; monetary affairs, namely, financial information, management and analyisis services; real estate affairs, namely, investment; banking; credit bureaux; accommodation bureaux, namely, residential lettings and property management; debt collection agencies; real estate management; financial analysis; health insurance underwriting; life insurance underwriting; insurance underwriting; financial consultancy; financial guarantees; insurance information; fund investments; insurance brokerage; housing agents in the nature of real estate brokerage; financing services; provident fund investment services; fiduciary representative servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 12, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jan 12, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 28, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 3, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 3, 2022INPCINVALIDATION PROCESSED—
May 3, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 3, 2021C71TCANCELLED SECTION 71—
Aug 1, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 17, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 29, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 29, 2015FIMPFINAL DISPOSITION PROCESSED—
May 31, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 17, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 2, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 12, 2014NPUBNOTICE OF PUBLICATION—
Oct 29, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 27, 2014ALIEASSIGNED TO LIE—
Oct 8, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 3, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2014ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 27, 2014CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 26, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 22, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 22, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 22, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 25, 2013RFNTREFUSAL PROCESSED BY IB—
Dec 3, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 3, 2013RFRRREFUSAL PROCESSED BY MPU—
Nov 26, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 25, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2013DOCKASSIGNED TO EXAMINER—
Nov 15, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance